Dr. D. CBD

Sep
20
2018

Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.

Written by Dr D / Arthritis
Involvement of the endocannabinoid system in osteoarthritis pain.
Sep
20
2018

Involvement of the endocannabinoid system in osteoarthritis pain.

Written by Dr D / Arthritis
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Jul
16
2018

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.
May
28
2018

Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.

Nov
22
2017

Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress

Nov
22
2017

Cannabis decreases Opiate use in chronic pain patients

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.
Nov
22
2017

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
Nov
22
2017

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Written by Dr D / Arthritis
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.
Nov
22
2017

Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
Nov
22
2017

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.

Written by Dr D / Arthritis, CBD, Pain